Acitretin in psoriasis: an overview of adverse effects (Q33718586)

28 July 2017

1 reference

title

Acitretin in psoriasis: an overview of adverse effects (English)

1 reference

28 July 2017

1 reference

Katz HI

1

1 reference

28 July 2017

Waalen J

series ordinal

2

1 reference

28 July 2017

Leach EE

series ordinal

3

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

Journal of the American Academy of Dermatology

28 July 2017

1 reference

28 July 2017

41

1 reference

28 July 2017

3 Pt 2

1 reference

28 July 2017

S7-S12

1 reference

Current use and future potential role of retinoids in dermatology

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Systemic retinoids. What's new?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Pharmacokinetics of acitretin and etretinate.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

A potentially new metabolic pathway: ethyl esterification of acitretin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Acitretin biotransformation into etretinate: role of ethanol on in vitro hepatic metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Food increases the bioavailability of acitretin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Retinoic acid embryopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Side-effect profile of acitretin therapy in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Acitretin. A review of its pharmacology and therapeutic use

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Oral retinoids--efficacy and toxicity in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

Acitretin (RO10-1670) and oral contraceptives: interaction study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2970359-2

7 January 2021

10.1016/S0190-9622(99)70359-2

Identifiers

DOI

1 reference

28 July 2017

1 reference